Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 2

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 2
---
,000,000 Depositary Shares, or the Purchase Shares, underlying 350,000,000,000 Ordinary Shares by that we may elect, in our sole discretion, to issue and sell to the selling shareholder identified in this prospectus, from time to time from and after the Commencement Date (as defined herein) under the Purchase Agreement (as defined herein), and subject to applicable stock exchange rules (assuming the shares to be issued and sold at a price of $1.00 per share) and (b) up to 875,000 Depositary Shares, or the Commitment Shares, underlying 8,750,000,000 Ordinary Shares that may be issued to the selling shareholder identified in this prospectus to release the Company of its liability to pay the Commitment Fee (as defined herein) as consideration for it entering into the Purchase Agreement (assuming the shares to be issued at a price of $1.00 per share). The information included in this filing updates the Registration Statement and the prospectus contained therein. No additional securities are being registered under this Post-Effective Amendment No. 1. Accordingly, this Post-Effective Amendment No. 1 concerns only the offer and sale of Purchase Shares and/or Commitment Shares issuable from time to time to the selling shareholder identified in this prospectus. All applicable registration fees were paid at the time of the original filing of the Registration Statement.

The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted.

<div align='center'>PRELIMINARY PROSPECTUS—SUBJECT TO COMPLETION, DATED APRIL 29, 2025

341,352,000,000 Ordinary Shares Representing 34,135,200 American Depositary Shares

___________________</div>

This prospectus relates to the potential offer and sale from time to
time by C/M Capital Master Fund, LP, or the Selling Shareholder, of up to 341,352,000,000 of our ordinary shares, nominal value £0.00005 per share, or Ordinary Shares, represented by 34,135,200 American Depositary Shares, or Depositary
Shares, that have been or may be issued by us to the Selling Shareholder pursuant to a